reglab/statecodes huggingface dataset:
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 4 - Medication Security and Diversion Prevention › Article 3 - Medication Handling and Security › Section 10255 - Medications Record Keeping

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Each
					 program shall maintain accurate records of medications used in replacement narcotic
					 therapy traceable to specific patients, showing dates, quantity, and batch code
					 marks of the medications.
(1) These records shall
					 be maintained by a physician, pharmacist, or health professional authorized to
					 compound, administer or dispense medications used in replacement narcotic
					 therapy.
(2) These records shall be
					 retained for a period of three years.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 4 - Medication Security and Diversion Prevention › Article 3 - Medication Handling and Security › Section 10256 - Methadone Preparation, Administering or Furnishing. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10256 to new subsection
						10260(a) filed 6-3-91
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11215,
						  11216
						  and
						  11876(a),
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 4 - Medication Security and Diversion Prevention › Article 3 - Medication Handling and Security › Section 10258 - Methadone Record Keeping. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10258 to new subsection
						10255(a) filed 6-3-91
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11215,
						  11216
						  and
						  11876(a),
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 4 - Medication Security and Diversion Prevention › Article 3 - Medication Handling and Security › Section 10260 - Administration or Dispensing of Medications

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) The program
					 physician shall be responsible for administering or dispensing to patients all
					 medications used in replacement narcotic therapy.
(b) Under the program physician's direction,
					 appropriately licensed program personnel may administer or dispense these
					 medications to patients as authorized by Section
					 11215 of
					 the Health and Safety Code.
(c) Each
					 program shall use the following procedures when administering or dispensing
					 medications used for replacement narcotic therapy or furnishing methadone:
(1) Methadone shall be administered or dispensed
					 to patients orally in liquid formulation.
(2) Methadone doses ingested at the program
					 facility shall be diluted in a solution that has a volume of not less than two
					 ounces. The medical director shall determine whether to dilute take-home medication
					 doses given to patients in maintenance treatment.
(3) If the medical director determines not to
					 dilute take-home medication, the reason for that decision shall be documented in the
					 patient record.
(4) A program staff
					 member shall observe ingestion of each medication dose administered at the program
					 facility.
(5) Each program shall devise
					 precautions to prevent diversion of all medications used in replacement narcotic
					 therapy.
(6) Methadone shall be
					 available seven days per week.
(7) No
					 patient shall be allowed to access a program's supply of medications, act as an
					 observer in the collection of patient body specimens used for testing or analysis of
					 samples for illicit drug use, or handle these specimens.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10270 - Criteria for Patient Selection

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Before
					 admitting an applicant to detoxification or maintenance treatment, the medical
					 director shall either conduct a medical evaluation or document his or her review and
					 concurrence of a medical evaluation conducted by the physician extender. At a
					 minimum this evaluation shall consist of:
(1) A
					 medical history that includes the applicant's history of illicit drug use;
(2) An optional laboratory test for the
					 determination of human immunodeficiency virus (HIV) in accordance with Division 105,
					 Part 4, Chapter 7 of Health and Safety Code; and laboratory tests for determination
					 of narcotic drug use, hepatitis C virus (HCV), tuberculosis, and syphilis (unless
					 the medical director has determined the applicant's subcutaneous veins are severely
					 damaged to the extent that a blood specimen cannot be obtained); and
(3) A physical examination that includes:
(A) An evaluation of the applicant's organ systems
					 for possibility of infectious diseases; pulmonary, liver, or cardiac abnormalities;
					 and dermatologic sequelae of addiction;
(B) A record of the applicant's vital signs
					 (temperature, pulse, blood pressure, and respiratory rate);
(C) An examination of the applicant's head, ears,
					 eyes, nose, throat (thyroid), chest (including heart and lungs), abdomen,
					 extremities, skin, and general appearance;
(D) An assessment of the applicant's neurological
					 system; and
(E) A record of an overall
					 impression that identifies any medical condition or health problem for which
					 treatment is warranted.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10272 - Operational Procedures to be Set Forth in Protocol. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10272 to new subsection
						10255(b) filed 6-3-91
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11215,
						  11216,
						  11217
						  and
						  11876(a),
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10274 - Procedures in the Event of Methadone Maintenance Patient Incarceration or Hospitalization. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former subsection
						10274(a) to new
						subsection 10030(a)(31) and former
						subsections 10274(b)-(c) to new
						subsection 10190(b) filed 6-3-91
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11215,
						  11216,
						  11222,
						  11876(a)
						  and
						  11880,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10276 - Procedures in the Event of Methadone Detoxification Patient Incarceration or Hospitalization. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former subsection
						10276(a) to new
						subsection 10190(a) and former
						subsection 10276(b) to new section
						10185 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11215,
						  11216,
						  11876(a)
						  and
						  11880,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10278 - Procedures in the Event of Emergency or Disaster. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10278 to new section
						10180 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a)
						  and
						  11880,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10280 - Patient Orientation

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Programs
					 shall advise patients of the nature and purpose of treatment, which shall include,
					 but not be limited to, the following information.
(1) The addicting nature of medications used in
					 replacement narcotic therapy.
(2) The
					 hazards and risks involved in replacement narcotic therapy.
(3) The patient's responsibility to the
					 program.
(4) The program's
					 responsibility to the patient.
(5) The
					 patient's participation in the program is wholly voluntary and the patient may
					 terminate his/her participation in the program at any time without
					 penalty.
(6) The patient will be tested
					 for evidence of use of opioids and other illicit drugs.
(7) The patient's medically determined dosage
					 level may be adjusted without the patient's knowledge, and at some later point the
					 patient's dose may contain no medications used in replacement narcotic
					 therapy.
(8) Take-home medication which
					 may be dispensed to the patient is only for the patient's personal use.
(9) Misuse of medications will result in specified
					 penalties within the program and may also result in criminal prosecution.
(10) The patient has a right to a humane procedure
					 of withdrawal from medications used in replacement narcotic therapy and a procedure
					 for gradual withdrawal is available.
(11) Possible adverse effects of abrupt withdrawal
					 from medications used in replacement narcotic therapy.
(12) Protection under the confidentiality
					 requirements.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10284 - Body Fluid Testing by Approved Laboratories. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10284 to new section
						10320 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Section
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a),
						  11880
						  and
						  11881,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10285 - Patient Orientation for Female Patients of Childbearing Age

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Each
					 program shall provide the following orientation to female patients of childbearing
					 age:
(1) Knowledge of the effects of medications
					 used in replacement narcotic therapy on pregnant women and their unborn children is
					 presently inadequate to guarantee that these medications may not produce significant
					 or serious side effects.
(2) These
					 medications are transmitted to the unborn child and may cause physical
					 dependence.
(3) Abrupt withdrawal from
					 these medications may adversely affect the unborn child.
(4) The use of other medications or illicit drugs
					 in addition to medications used in replacement narcotic therapy may harm the patient
					 and/or unborn child.
(5) The patient
					 should consult with a physician before nursing.
(6) The child may show irritability or other ill
					 effects from the patient's use of these medications for a brief period following
					 birth.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10286 - Procedures for Urinalysis. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10286 to new section
						10310 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a),
						  11880
						  and
						  11881,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10288 - Urinalysis, Substances Tested for. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10288 to new section
						10315 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a),
						  11880
						  and
						  11881,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10292 - Urinalysis Records. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10292 to new section
						10330 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Section
						  11876(a),
						  11880
						  and
						  11881,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 1 - Patient Selection and Orientation › Section 10294 - Urinalysis, Staff Training. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10294 to new section
						10140 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a),
						  11880
						  and
						  11881,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 2 - Patient Attendance and Absence › Section 10296 - Urinalysis Reliability. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10296 to new section
						10325 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a),
						  11880
						  and
						  11881,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 2 - Patient Attendance and Absence › Section 10300 - Patient Absence

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Patient in
					 Detoxification Treatment
(1) If a patient in
					 detoxification treatment misses appointments for three consecutive days or more
					 without notifying the program, the patient's episode of treatment may be terminated
					 by the medical director or program physician and the discharge shall be noted in the
					 record.
(2) A patient in detoxification
					 treatment that is discharged pursuant to Subsection (a)(1) of this regulation may be
					 continued in treatment by the program physician if medically indicated, based upon
					 establishment of a legitimate reason for absence. The reasons for continuation of
					 treatment shall be documented in the patient's record.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10305 - Patient Treatment Plans

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) The primary
					 counselor shall enter in the patient's record his or her name and the date the
					 patient was assigned to the counselor.
(b) Detoxification Treatment Plan Requirements.
					 Programs shall develop an individualized treatment plan for each patient which shall
					 include:
(1) Provisions to assist the patient to
					 understand illicit drug addictions and how to deal with them.
(2) Provisions for furnishing services to the
					 patient as needed when the period of detoxification treatment is
					 completed.
(3) The treatment services
					 required and a description of the role they play in achieving the stated
					 goals.
(4) The type and frequency of
					 scheduled counseling services.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10310 - Procedures for Collection of Patient Body Specimens

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Each
					 program shall set forth in its protocol a plan for collection of patient body
					 specimens for testing or analysis of samples for illicit drug use that describes the
					 procedures to be used for:
(1) Assuring the
					 reliability of its body patient specimen collection procedure.
(2) Storage of body patient specimens in a secure
					 place to avoid substitution.
(3) The
					 substances for which samples of patient body specimens are to be analyzed pursuant
					 to section 10315.
(4) Usage of test or analysis results in patient
					 evaluation and treatment.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10314 - Procedures for Patient Records. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10314 to new section
						10160 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 2 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a), (b), and
						  (c) and
						  11880,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10315 - Substances to be Tested or Analyzed for in Samples Collected from Patient Body Specimens

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Programs
					 shall have samples collected from each patient body specimen tested or analyzed for
					 evidence of the following substances in a patient's system:
(1) Methadone and its primary
					 metabolite.
(2) Opioids.
(3) Cocaine.
(4) Amphetamines.
(5) Barbiturates.
(6) Benzodiazepines.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10316 - Contents of Program Patient Records. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10316 to new subsection
						10165(a) filed 6-3-91
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a), (b), and
						  (c) and
						  11880,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10318 - Additional Requirements for Contents of Methadone Maintenance Patient Records. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10318 to new subsection
						10165(c) filed 6-3-91
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a), (b), and
						  (c) and
						  11880,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10322 - Confidentiality Requirement. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10322 to new section
						10155 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cite: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a)
						  and
						  11879,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10325 - Reliability of Tests or Analyses for Illicit Drug Use

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Each program shall participate in and maintain records
						pursuant to a quality control program, prescribed by the State Department of Health
						Services pursuant to section
						1192, title 17, California Code of
						Regulations, to examine the reliability of test or analyses for illicit drug use and
						their results.
1. Change
						without regulatory effect renumbering and amending parts of former section
						10296 to
						10325 filed 6-3-91 pursuant to section
						100, title 1, California Code of
						Regulations (Register 91, No. 34).
2. Amendment of section heading and
						section filed 3-15-96 as an emergency; operative 3-15-96 (Register 96, No. 11). A
						Certificate of Compliance must be transmitted to OAL by 7-13-96 or emergency
						language will be repealed by operation of law on the following day.
3.
						Amendment of section heading and section refiled 7-8-96 as an emergency; operative
						7-12-96 (Register 96, No. 28). A Certificate of Compliance must be transmitted to
						OAL by 11-12-96 or emergency language will be repealed by operation of law on the
						following day.
4. Amendment of section heading and section refiled
						10-23-96 as an emergency; operative 10-29-96 (Register 96, No. 43). A Certificate of
						Compliance must be transmitted to OAL by 2-26-97 or emergency language will be
						repealed by operation of law on the following day.
5. Amendment of
						section heading and section refiled 2-11-97 as an emergency; operative 2-24-97
						(Register 97, No. 7). A Certificate of Compliance must be transmitted to OAL by
						6-24-97 or emergency language will be repealed by operation of law on the following
						day.
6. Certificate of Compliance as to 2-11-97 order transmitted to OAL
						3-4-97; disapproved by OAL and order of repeal as to 2-11-97 order filed 4-15-97
						(Register 97, No. 16).
7. Amendment of section heading and section filed
						4-15-97 as an emergency; operative 4-15-97 (Register 97, No. 16). A Certificate of
						Compliance must be transmitted to OAL by 8-13-97 or emergency language will be
						repealed by operation of law on the following day.
8. Certificate of
						Compliance as to 4-15-97 order transmitted to OAL 6-2-97 and filed 6-13-97 (Register
						97, No. 24).
9. Change without regulatory effect amending section and
						NOTE filed 4-19-2006 pursuant to section
						100, title 1, California Code of
						Regulations (Register 2006, No. 16).
Note: Authority cited: Sections
						  11755,
						  11835,
						  11839.3
						  and
						  11839.20,
						  Health and Safety Code. Reference: Sections
						  11839.3,
						  11839.20
						  and
						  11839.21,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10328 - Scheduled Termination of Methadone Maintenance. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10328 to new section
						10410 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Sections
						  11876(a)
						  and
						  11880,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10330 - Test or Analysis Records for Illicit Drug Use

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Each
					 program shall maintain in every patient's file the following information:
(1) The date the patient body specimen was
					 collected;
(2) The test or analysis
					 results; and
(3) The date the program
					 received the results of the test or analysis.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10332 - Methadone Maintenance Fair Hearings. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering former section
						10332 to new section
						10420 filed 6-3-91 pursuant to title 1,
						section 100, California Code of Regulations
						(Register 91, No. 34).
2. Change without regulatory effect deleting text
						and adding HISTORY 1 as editorial corrections of printing errors filed 9-24-93
						pursuant to title 1, section
						100, California Code of Regulations
						(Register 93, No. 39).
Note: Authority cited: Sections
						  11864
						  and
						  11876(a),
						  Health and Safety Code. Reference: Section
						  11876(a),
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10335 - Failure of Patients to Provide a Body Specimen

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
When a patient fails to provide a body specimen when required,
						the program shall proceed as though the patient's sample from his or her body
						specimen disclosed the presence of an illicit drug(s). Such failures shall be noted
						in the patient's records.
1. Change
						without regulatory effect renumbering and amending parts of former section
						10290 to
						10335 filed 6-3-91 pursuant to section
						100, title 1, California Code of
						Regulations (Register 91, No. 34).
2. Amendment of section heading and
						section filed 3-15-96 as an emergency; operative 3-15-96 (Register 96, No. 11). A
						Certificate of Compliance must be transmitted to OAL by 7-13-96 or emergency
						language will be repealed by operation of law on the following day.
3.
						Amendment of section heading and section refiled 7-8-96 as an emergency; operative
						7-12-96 (Register 96, No. 28). A Certificate of Compliance must be transmitted to
						OAL by 11-12-96 or emergency language will be repealed by operation of law on the
						following day.
4. Amendment of section heading and section refiled
						10-23-96 as an emergency; operative 10-29-96 (Register 96, No. 43). A Certificate of
						Compliance must be transmitted to OAL by 2-26-97 or emergency language will be
						repealed by operation of law on the following day.
5. Amendment of
						section heading and section refiled 2-11-97 as an emergency; operative 2-24-97
						(Register 97, No. 7). A Certificate of Compliance must be transmitted to OAL by
						6-24-97 or emergency language will be repealed by operation of law on the following
						day.
6. Certificate of Compliance as to 2-11-97 order transmitted to OAL
						3-4-97; disapproved by OAL and order of repeal as to 2-11-97 order filed 4-15-97
						(Register 97, No. 16).
7. Amendment of section heading and section filed
						4-15-97 as an emergency; operative 4-15-97 (Register 97, No. 16). A Certificate of
						Compliance must be transmitted to OAL by 8-13-97 or emergency language will be
						repealed by operation of law on the following day.
8. Certificate of
						Compliance as to 4-15-97 order, including amendment, transmitted to OAL 6-2-97 and
						filed 6-13-97 (Register 97, No. 24).
9. Change without regulatory effect
						amending NOTE filed 4-19-2006 pursuant to section
						100, title 1, California Code of
						Regulations (Register 2006, No. 16).
Note: Authority cited: Sections
						  11755,
						  11835,
						  11839.3
						  and
						  11839.20,
						  Health and Safety Code. Reference: Sections
						  11839.3,
						  11839.20
						  and
						  11839.21,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10340 - Medical Care. [Repealed]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Change
						without regulatory effect renumbering and amending parts of former section
						10012 to
						10340 filed 6-3-91 pursuant to section
						100, title 1, California Code of
						Regulations (Register 91, No. 34).
2. Amendment of subsection (a) and
						NOTE filed 3-15-96 as an emergency; operative 3-15-96 (Register 96, No. 11). A
						Certificate of Compliance must be transmitted to OAL by 7-13-96 or emergency
						language will be repealed by operation of law on the following day.
3.
						Amendment of subsection (a) and NOTE refiled 7-8-96 as an emergency; operative
						7-12-96 (Register 96, No. 28). A Certificate of Compliance must be transmitted to
						OAL by 11-12-96 or emergency language will be repealed by operation of law on the
						following day.
4. Amendment of subsection (a) and NOTE refiled 10-23-96
						as an emergency; operative 10-29-96 (Register 96, No. 43). A Certificate of
						Compliance must be transmitted to OAL by 2-26-97 or emergency language will be
						repealed by operation of law on the following day.
5. Amendment of
						subsection (a) and NOTE refiled 2-11-97 as an emergency; operative 2-24-97 (Register
						97, No. 7). A Certificate of Compliance must be transmitted to OAL by 6-24-97 or
						emergency language will be repealed by operation of law on the following
						day.
6. Certificate of Compliance as to 2-11-97 order transmitted to OAL
						3-4-97; disapproved by OAL and order of repeal as to 2-11-97 order filed 4-15-97
						(Register 97, No. 16).
7. Amendment of subsection (a) and NOTE filed
						4-15-97 as an emergency; operative 4-15-97 (Register 97, No. 16). A Certificate of
						Compliance must be transmitted to OAL by 8-13-97 or emergency language will be
						repealed by operation of law on the following day.
8. Certificate of
						Compliance as to 4-15-97 order transmitted to OAL 6-2-97 and filed 6-13-97 (Register
						97, No. 24).
9. Change without regulatory effect amending NOTE filed
						4-19-2006 pursuant to section
						100, title 1, California Code of
						Regulations (Register 2006, No. 16).
10. Repealer filed 5-7-2020;
						operative 7-1-2020 (Register 2020, No. 19).
Note: Authority cited: Sections
						  11755,
						  11835,
						  11839.3
						  and
						  11839.20,
						  Health and Safety Code. Reference: Section
						  11839.3,
						  Health and Safety Code.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10345 - Counseling Services in Maintenance Treatment

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Upon
					 completion of the initial treatment plan, the primary counselor shall arrange for
					 the patient to receive at the licensed program a minimum of fifty (50) minutes of
					 counseling services per calendar month, except as allowed in subsection (e) of this
					 section, and shall be in accordance with the following:
(b) A counseling session shall qualify for the
					 requirement in subsection (a) if:
(1) The program
					 staff member conducting the session meets minimum counselor qualifications, as
					 specified in Section
					 10125.
(2) The session is conducted in a private setting
					 in accordance with all applicable federal and state regulations regarding
					 confidentiality.
(3) The format of the
					 counseling session shall be one of the following:
(A) Individual session, with face-to-face
					 discussion with the patient, on a one-on-one basis, on issues identified in the
					 patient's treatment plan.
(B) Group
					 session, with a minimum of two patients and no more than twelve patients and having
					 a clear goal and/or purpose that is a common issue identified in the treatment plans
					 of all participating patients.
(C)
					 Medical psychotherapy session, with face-to-face discussion conducted by the medical
					 director on a one-on-one basis with the patient, on issues identified in the
					 patient's treatment plan.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10355 - Medication Dosage Levels

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a)
					 Detoxification Dosage Levels.
(1) The medical
					 director or program physician shall individually determine each patient's medication
					 schedule based on the following criteria:
(A)
					 Medications shall be administered daily under observation;
(B) Dosage levels shall not exceed that which is
					 necessary to suppress withdrawal symptoms; and
(C) Schedules shall include initial, stabilizing,
					 and reducing dosage amounts for a period of not more than 21
					 days.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 3 - Treatment Services › Section 10360 - Additional Requirements for Pregnant Patients

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Within
					 fourteen (14) calendar days from the date of the primary counselor's knowledge that
					 the patient may be pregnant, as documented in the patient's record, the medical
					 director shall review, sign, and date a confirmation of pregnancy. Also within this
					 time frame, the medical director shall document his or her:
(1) Acceptance of medical responsibility for the
					 patient's prenatal care; or
(2)
					 Verification that the patient is under the care of a physician, physician assistant,
					 or nurse practitioner licensed by the State of California and trained in obstetrics
					 and/or gynecology, or a licensed midwife or certified nurse midwife licensed by the
					 State of California.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 4 - Take-Home Medication Privileges › Section 10365 - Take-Home Medication Procedures

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Each program shall ensure compliance with the following
						procedures when granting take-home medication privileges to a patient in maintenance
						treatment:
(a) The medical director or
					 program physician shall determine the quantity of take-home medication dispensed to
					 a patient.
(b) The program shall
					 instruct each patient of his/her obligation to safeguard the take-home
					 medication.
(c) The program shall
					 utilize containers for take-home doses which comply with the special packaging
					 requirements as set forth in Section
					 1700.14, Title 16, Code of Federal
					 Regulations.
(d) The program shall label
					 each take-home dosage container indicating:
(1)
					 The facility's name and address;
(2) The
					 telephone number of the program;
(3) The
					 24-hour emergency telephone number if different from subsection (d)(2);
(4) The name of the medication;
(5) The name of the prescribing medical director
					 or program physician;
(6) The name of
					 the patient;
(7) The date issued;
					 and
(8) The following warning:
					 Poison--May Be Fatal to Adult or Child; Keep Out of Reach of Children.
The program may put other information on the label provided it
						does not obscure the required information.
California Code of Regulations › Title 9 - Rehabilitative and Developmental Services › Division 4 - Department of Alcohol and Drug Programs › Chapter 4 - Narcotic Treatment Programs › Subchapter 5 - Patient Treatment › Article 4 - Take-Home Medication Privileges › Section 10370 - Criteria for Take-Home Medication Privileges

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Methadone,
					 buprenorphine and buprenorphine products shall only be provided to a patient as
					 take-home medication if the medical director or program physician has determined, in
					 his or her clinical judgment, that the patient is responsible in handling narcotic
					 medications, is adhering to program requirements, and has documented his or her
					 rationale in the patient's record. The rationale shall be based on consideration of
					 the following criteria:
(1) Absence of use of
					 illicit drugs and abuse of other substances, including alcohol;
(2) Regularity of program attendance for
					 replacement narcotic therapy and counseling services;
(3) Absence of serious behavioral problems while
					 at the program;
(4) Absence of known
					 criminal activity, including the selling or distributing of illicit drugs;
(5) Stability of the patient's home environment
					 and social relationships;
(6) Length of
					 time in maintenance treatment;
(7)
					 Assurance that take-home medication can be safely stored within the patient's home;
					 and
(8) Whether the rehabilitative
					 benefit to the patient derived from decreasing the frequency of program attendance
					 outweighs the potential risks of diversion.